Abstract 3998: The IGF1 receptor/insulin receptor dual kinase inhibitor BMS-754807 targets the cancer stem cell population in addition to its synergism with Lapatinib in colorectal cancer.
2018 ◽
Keyword(s):
2021 ◽
pp. 106085
Keyword(s):
2018 ◽
Keyword(s):
2010 ◽
Vol 78
(3)
◽
pp. S221
2011 ◽
Vol 104
(11)
◽
pp. 1730-1738
◽